Previous 10 | Next 10 |
Zynerba Pharmaceuticals (NASDAQ: ZYNE ) -14% on possible Zygel safety signal . More news on: Zynerba Pharmaceuticals, Inc., FedEx Corporation, Onconova Therapeutics, Inc., Stocks on the move, Read more ...
Gainers: Aclaris Therapeutics (NASDAQ: ACRS ) +68% . Avadel Pharmaceuticals plc (NASDAQ: AVDL ) +20% . BioCardia ( OTCQB:BCDA ) +15% . Lexicon Pharmaceuticals (NASDAQ: LXRX ) +14% . Earthstone Energy (NYSE: ESTE ) +14% . Pier 1 Imports (NYSE: PIR ) +15% . SunPower Corporation (...
Onconova Therapeutics (NASDAQ: ONTX ) -11% ahead of rigosertib data presentation . More news on: Onconova Therapeutics, Inc., Corning Incorporated, Funko, Inc., Stocks on the move, Read more ...
Gainers: Alder BioPharmaceuticals (NASDAQ: ALDR ) +84% . SemGroup Corporation (NYSE: SEMG ) +63% . Yuma Energy (NYSEMKT: YUMA ) +63% . Wins Finance Holdings (NASDAQ: WINS ) +55% . Whiting Petroleum Corporation (NYSE: WLL ) +43% . New Concept Energy (NYSEMKT: GBR ) +34% . Califo...
NEWTOWN, Pa., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on myelodysplastic syndromes (MDS), will present at the RAS-Targeted Drug Discovery S...
Onconova Therapeutics, Inc. (ONTX) Q2 2019 Earnings Conference Call August 14, 2019 9:00 a.m. ET Company Participants Avi Oler - VP, Corporate Development, General Counsel Steve Fruchtman - President and CEO Mark Guerin - CFO Ric Woodman - Chief Medical Officer Conference Ca...
Onconova Therapeutics ( ONTX ) Q2 results : Revenues: $2M. More news on: Onconova Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, , Read more ...
Onconova Therapeutics (NASDAQ: ONTX ): Q2 GAAP EPS of -$0.60 beats by $0.28 . More news on: Onconova Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
NEWTOWN, Pa., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on Myelodysplastic Syndromes (MDS), today provided a corporate update and reported ...
NEWTOWN, Pa. and SOUTH SAN FRANCISCO, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics , Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on Myelodysplastic Syndromes (MDS), and Mis...
News, Short Squeeze, Breakout and More Instantly...
Onconova Therapeutics Inc. Company Name:
ONTX Stock Symbol:
NASDAQ Market:
Onconova Therapeutics Inc. Website:
Closing cash balance of approximately $28 million expected from concurrent private placement led by OrbiMed and Torrey Pines Funding expected to ...
NEWTOWN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (Nasdaq: TRAW, “Traws”, the “Company”) today announced it has granted equity awards to new employees who joined Traws in connection with the recent acquisition of Trawsfynydd Therapeutics, Inc. by Onco...
Closing cash balance of approximately $28 million expected from concurrent private placement led by OrbiMed and Torrey Pines Funding expected to advance development of three potential best-in-class/class leading assets: viroksavir, a cap-dependent endonuclease inhibitor for influenza; tra...